ICARES Medicus, Inc. (TPEX:6612)

Market Cap	3.50B
Revenue (ttm)	1.09B
Net Income (ttm)	63.38M
Shares Out	47.38M
EPS (ttm)	1.34
PE Ratio	55.06
Forward PE	n/a
Dividend	0.27 (0.37%)
Ex-Dividend Date	Aug 22, 2025

Volume	13,193
Average Volume	24,521
Open	73.90
Previous Close	74.90
Day's Range	73.60 - 73.90
52-Week Range	72.80 - 123.64
Beta	0.39
RSI	19.44
Earnings Date	Mar 12, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.